Ring Therapeutics
PrivateLast Round
Series C
Mar 9, 2023
Total Funding Raised
$253.5M
Company Overview
Ring Therapeutics is a biotechnology company that develops programmable medicines utilizing a novel viral vector platform based on the human commensal virome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ring Therapeutics Comparables
Compare Ring Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capsida Biotherapeutics | 80% | |
| Senda Biosciences | 80% | |
| Vector BioPharma | 77% | |
Ring Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 9, 2023 | ||||
| Series B | Jul 28, 2021 | ||||
| Series A | Dec 19, 2019 |
Key People
Founding team and executive leadership
Ring Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Altitude Life Science Ventures | Series B, Series C |
| Invus Opportunities | Series C, Series B |
| CJ Investment | Series C |
| T. Rowe Price | Series C, Series B |
| Alexandria Venture Investments | Series C |
| UPMC Enterprises | Series C, Series B |
| Partners Investment | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2025
New data shows successful infectivity and expression of AnelloVectors.
- May 14, 2025
Presented new data at the ASCGT Conference in New Orleans.
Ring Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ring Therapeutics's valuation, stock price, and market status.